193 related articles for article (PubMed ID: 28595013)
1. Fibroblast Activation Protein α Activated Tripeptide Bufadienolide Antitumor Prodrug with Reduced Cardiotoxicity.
Deng LJ; Wang LH; Peng CK; Li YB; Huang MH; Chen MF; Lei XP; Qi M; Cen Y; Ye WC; Zhang DM; Chen WM
J Med Chem; 2017 Jul; 60(13):5320-5333. PubMed ID: 28595013
[TBL] [Abstract][Full Text] [Related]
2. Tumor-targeting efficacy of a BF211 prodrug through hydrolysis by fibroblast activation protein-α.
Chai XP; Sun GL; Fang YF; Hu LH; Liu X; Zhang XW
Acta Pharmacol Sin; 2018 Mar; 39(3):415-424. PubMed ID: 29119969
[TBL] [Abstract][Full Text] [Related]
3. A novel FAPα-based Z-Gly-Pro epirubicin prodrug for improving tumor-targeting chemotherapy.
Wang J; Li Q; Li X; Yuan W; Huang S; Cai S; Xu J
Eur J Pharmacol; 2017 Nov; 815():166-172. PubMed ID: 28919026
[TBL] [Abstract][Full Text] [Related]
4. Enhanced anti-tumor efficiency of gemcitabine prodrug by FAPα-mediated activation.
Sun J; Yang D; Cui SH; Zhang HT; Fu Y; Wang JC; Zhang Q
Int J Pharm; 2019 Mar; 559():48-57. PubMed ID: 30677483
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Novel 3,11-Bispeptide Ester Arenobufagin Derivatives with Potential in Vivo Antitumor Activity and Reduced Cardiotoxicity.
Tang W; Zhang Y; Yang K; Ma J; Dong L; Wu C; Lv R; Wang C; Luo C; Zhang H; Miao Z; Wu Y
Chem Biodivers; 2023 Feb; 20(2):e202200911. PubMed ID: 36627123
[TBL] [Abstract][Full Text] [Related]
6. Novel octapeptide-DTX prodrugs targeting MMP-7 as effective agents for the treatment of colorectal cancer with lower systemic toxicity.
Liu ZY; Tang ML; Ning JF; Hao YP; Zhou L; Sun X
Eur J Med Chem; 2020 May; 193():112194. PubMed ID: 32203786
[TBL] [Abstract][Full Text] [Related]
7. Hybrids of arenobufagin and benzoisoselenazol reducing the cardiotoxicity of arenobufagin.
Hou W; Huang ZX; Xu HG; Lin J; Zhang DM; Peng QL; Lin H; Chang YQ; Wang LH; Yao Z; Sun PH; Chen WM
Bioorg Med Chem Lett; 2018 Nov; 28(20):3391-3394. PubMed ID: 30181060
[TBL] [Abstract][Full Text] [Related]
8. Direct Real-Time Monitoring of Prodrug Activation by Chemiluminescence.
Gnaim S; Scomparin A; Das S; Blau R; Satchi-Fainaro R; Shabat D
Angew Chem Int Ed Engl; 2018 Jul; 57(29):9033-9037. PubMed ID: 29786931
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug.
Huang S; Fang R; Xu J; Qiu S; Zhang H; Du J; Cai S
J Drug Target; 2011 Aug; 19(7):487-96. PubMed ID: 21284542
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment.
Deng LJ; Li Y; Qi M; Liu JS; Wang S; Hu LJ; Lei YH; Jiang RW; Chen WM; Qi Q; Tian HY; Han WL; Wu BJ; Chen JX; Ye WC; Zhang DM
Eur J Pharmacol; 2020 Nov; 887():173379. PubMed ID: 32758567
[TBL] [Abstract][Full Text] [Related]
11. Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug.
Brennen WN; Rosen DM; Wang H; Isaacs JT; Denmeade SR
J Natl Cancer Inst; 2012 Sep; 104(17):1320-34. PubMed ID: 22911669
[TBL] [Abstract][Full Text] [Related]
12. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
Akinboye ES; Brennen WN; Rosen DM; Bakare O; Denmeade SR
Prostate; 2016 Jun; 76(8):703-14. PubMed ID: 26835873
[TBL] [Abstract][Full Text] [Related]
13. Microbial transformation of three bufadienolides by Nocardia sp. and some insight for the cytotoxic structure-activity relationship (SAR).
Zhang J; Sun Y; Liu JH; Yu BY; Xu Q
Bioorg Med Chem Lett; 2007 Nov; 17(22):6062-5. PubMed ID: 17911017
[TBL] [Abstract][Full Text] [Related]
14. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
[TBL] [Abstract][Full Text] [Related]
15. Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivatives.
Akinboye ES; Rosen MD; Bakare O; Denmeade SR
Bioorg Med Chem; 2017 Dec; 25(24):6707-6717. PubMed ID: 29153549
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, bioconversion, pharmacokinetic and pharmacodynamic evaluation of N-isopropyl-oxy-carbonyloxymethyl prodrugs of CZh-226, a potent and selective PAK4 inhibitor.
Guo J; Wang T; Wu T; Zhang K; Yin W; Zhu M; Pang Y; Hao C; He Z; Cheng M; Liu Y; Zheng J; Gu J; Zhao D
Eur J Med Chem; 2020 Jan; 186():111878. PubMed ID: 31757524
[TBL] [Abstract][Full Text] [Related]
17. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
[TBL] [Abstract][Full Text] [Related]
18. Lysosome-Targeting Amplifiers of Reactive Oxygen Species as Anticancer Prodrugs.
Daum S; Reshetnikov MSV; Sisa M; Dumych T; Lootsik MD; Bilyy R; Bila E; Janko C; Alexiou C; Herrmann M; Sellner L; Mokhir A
Angew Chem Int Ed Engl; 2017 Dec; 56(49):15545-15549. PubMed ID: 28994179
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Characterization of 3β-(N-Acetyl l-cysteine methyl ester)-2aβ,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer.
Escobar Z; Bjartell A; Canesin G; Evans-Axelsson S; Sterner O; Hellsten R; Johansson MH
J Med Chem; 2016 May; 59(10):4551-62. PubMed ID: 27111731
[TBL] [Abstract][Full Text] [Related]
20. Proteasome Inhibition Contributed to the Cytotoxicity of Arenobufagin after Its Binding with Na, K-ATPase in Human Cervical Carcinoma HeLa Cells.
Yue Q; Zhen H; Huang M; Zheng X; Feng L; Jiang B; Yang M; Wu W; Liu X; Guo D
PLoS One; 2016; 11(7):e0159034. PubMed ID: 27428326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
